Lifecore Biomedical Inc (LFCR)
7.31
+0.33
(+4.73%)
USD |
NASDAQ |
Nov 22, 16:00
7.29
-0.02
(-0.27%)
After-Hours: 20:00
Lifecore Biomedical Free Cash Flow: -8.79M for Aug. 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| August 31, 2024 | -8.79M |
| May 31, 2024 | -18.14M |
| February 29, 2024 | -33.58M |
| November 30, 2023 | -44.62M |
| August 31, 2023 | -47.84M |
| May 31, 2023 | -38.92M |
| February 28, 2023 | -41.44M |
| November 30, 2022 | -45.88M |
| August 31, 2022 | -49.91M |
| May 31, 2022 | -52.53M |
| February 28, 2022 | -48.55M |
| November 30, 2021 | -37.12M |
| August 31, 2021 | -28.23M |
| May 31, 2021 | -8.752M |
| February 28, 2021 | -18.05M |
| November 30, 2020 | -1.727M |
| August 31, 2020 | -15.91M |
| May 31, 2020 | -43.73M |
| February 29, 2020 | -39.48M |
| November 30, 2019 | -45.88M |
| August 31, 2019 | -31.88M |
| May 31, 2019 | -28.71M |
| February 28, 2019 | -29.07M |
| November 30, 2018 | -24.50M |
| August 31, 2018 | -23.79M |
| Date | Value |
|---|---|
| May 31, 2018 | -13.81M |
| February 28, 2018 | -7.293M |
| November 30, 2017 | 2.945M |
| August 31, 2017 | 0.222M |
| May 31, 2017 | 6.835M |
| February 28, 2017 | 14.49M |
| November 30, 2016 | -5.223M |
| August 31, 2016 | -9.345M |
| May 31, 2016 | -18.93M |
| February 29, 2016 | -13.80M |
| November 30, 2015 | -0.029M |
| August 31, 2015 | 4.01M |
| May 31, 2015 | 9.107M |
| February 28, 2015 | 5.691M |
| November 30, 2014 | 5.762M |
| August 31, 2014 | 5.811M |
| May 31, 2014 | 6.159M |
| February 28, 2014 | 7.058M |
| November 30, 2013 | 9.861M |
| August 31, 2013 | 9.49M |
| May 31, 2013 | 12.35M |
| February 28, 2013 | 21.10M |
| November 30, 2012 | 19.70M |
| August 31, 2012 | 17.07M |
| May 31, 2012 | 16.81M |
Free Cash Flow Range, Past 5 Years
-52.53M
Minimum
May 2022
-1.727M
Maximum
Nov 2020
-33.45M
Average
-39.20M
Median
Free Cash Flow Benchmarks
| AngioDynamics Inc | -26.58M |
| Precision Optics Corp Inc | -1.907M |
| Sage Therapeutics Inc | -320.15M |
| Outset Medical Inc | -126.18M |
| NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.643M |
| Cash from Investing (Quarterly) | -3.392M |
| Cash from Financing (Quarterly) | 1.093M |
| Free Cash Flow Per Share (Quarterly) | -0.1308 |
| Free Cash Flow to Equity (Quarterly) | -10.68M |
| Free Cash Flow to Firm (Quarterly) | 1.325M |
| Free Cash Flow Yield | -3.41% |